(Q35948269)

11 August 2017

title

The burden and cost of hospitalised varicella and zoster in Australian children (English)

1 reference

11 August 2017

1 reference

3

1 reference

11 August 2017

Jonathan R Carapetis

1

1 reference

11 August 2017

Diana M F Russell

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

755-761

1 reference

The effectiveness of the varicella vaccine in clinical practice

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Varicella vaccination in England and Wales: cost-utility analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

The cost-effectiveness of routine childhood varicella vaccination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Instituting a routine varicella vaccination program in Canada: an economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

The cost-effectiveness of varicella vaccine programs for Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Invasive group A streptococcal infections in children with varicella in Southern California.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Varicella-zoster virus infection in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.025

10.1016/J.VACCINE.2004.07.025

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference